[HTML][HTML] 间充质干细胞在2019新型冠状病毒肺炎(COVID-19)中的治疗潜能,临床研究与应用前景*
陈利军， 屈晶晶， 项春生 - 中国生物工程杂志, 2020 - manu60.magtech.com.cn
… 了MSC在COVID-19中的临床研究和当前面临的挑战,探讨了MSC治疗COVID-19的应用前景,为
MSC在COVID-19中的… Asian Pacific Journal of Allergy and Immunology, 2020,38(1):10-18. …
MSC在COVID-19中的… Asian Pacific Journal of Allergy and Immunology, 2020,38(1):10-18. …
[HTML][HTML] 靶向人白介素-6蛋白的治疗性单克隆抗体研究进展*
李开通， 刘金青， 蔡望伟， 肖曼， 沈倍奋… - 中国生物工程 …, 2022 - manu60.magtech.com.cn
… IL-6信号通路异常活化及功能失调与多… IL-6的异常表达在新型冠状病毒肺炎(COVID-19)细胞
因子风暴综合征(CSS)中也扮演重要角色.一般而言,阻断IL-6信号通路上的各关键节点,均可用于IL-6…
因子风暴综合征(CSS)中也扮演重要角色.一般而言,阻断IL-6信号通路上的各关键节点,均可用于IL-6…
脓毒症T 淋巴细胞亚群免疫监测的研究进展
张思也， 侯粲， 钟燕军， 伍国宝 - 中华重症医学电子杂志, 2021 - icu.cma-cmc.com.cn
… During pandemic of coronavirus disease 2019(COVID-19), severe COVID-19 patients also
… of T cell subsets counts, especially in patients with COVID-19, aiming to provide a monitoring …
… of T cell subsets counts, especially in patients with COVID-19, aiming to provide a monitoring …
[HTML][HTML] 44 例不同严重程度新型冠状病毒肺炎患者临床检测指标分析
胡文佳， 陈铁龙， 严亚军， 邓莉平… - 中华实验和临床 …, 2021 - zhsyhlcgrbzz.cma-cmc.com.cn
… COVID-19患者入院初期淋巴细胞及亚群,IL-6及病毒核酸水平存在差异,其中住院天数和IL-6异常
升高是重症化的危险因素,对COVID-19… a laboratory indexes for early warning mild/moderate …
升高是重症化的危险因素,对COVID-19… a laboratory indexes for early warning mild/moderate …
肝素在表达人ACE2 受体糖尿病小鼠模型中抗SARS-CoV-2 感染作用的研究
Z Zhang, N Zhang, X Lu, M Zhou, X Yan, W Gu… - Zoological …, 2023 - zoores.ac.cn
… However, the precise mechanisms responsible for the combined impact of coronavirus
disease 2019 (COVID-19) and diabetes have not yet been elucidated, and effective treatment …
disease 2019 (COVID-19) and diabetes have not yet been elucidated, and effective treatment …
2 例新型冠状病毒感染引起的弥漫性结缔组织病患者3 年随访观察.
温升慧， 宋优， 刘晓晶， 胡慧… - China Tropical Medicine, 2023 - search.ebscohost.com
… Abstract: To report on two patients with Coronavirus Disease 2019 (COVID-19) combined
with diffuse connective tissue disease caused by severe acute respiratory syndrome …
with diffuse connective tissue disease caused by severe acute respiratory syndrome …
[PDF][PDF] COVID-19 相关生物标志物的临床使用价值研究进展
王秋桐， 安耀震， 刘颖， 赵瑞 - 实用心脑肺 …, 2021 - boyuancaibian.oss-cn-beijing …
… 者IL-6 水平比非重型COVID-19 患者高出2.9 倍,ARDS 发 生率… 显示,IL-6 水平> 32.1 pg/ml 时
,可以用作预测 COVID-19 病情… ratio is an early warning signal of severe COVID-19[J]. Nan Fang …
,可以用作预测 COVID-19 病情… ratio is an early warning signal of severe COVID-19[J]. Nan Fang …
[HTML][HTML] 最新产品价格查看产品价格
EA Teslow - promega.com.cn
… COVID-19 patients produce neutralizing antibodies to the RBD domain of the SARS-CoV-2
S protein 30-35 . Lastly, COVID-19 … of pro-inflammatory cytokines, which contribute to disease…
S protein 30-35 . Lastly, COVID-19 … of pro-inflammatory cytokines, which contribute to disease…
[HTML][HTML] 新型冠状病毒感染与睡眠障碍关系研究进展
温玉墀， 张燕， 卿为家， 李广云， 李宏伟… - International Journal of …, 2024 - hanspub.org
… Abstract: COVID-19 is a new highly infectious disease caused by severe acute respiratory …
the pathogenesis, warning signals, and early intervention measures of COVID-19, so as to put …
the pathogenesis, warning signals, and early intervention measures of COVID-19, so as to put …
[HTML][HTML] 医学免疫学中西医融合教学的设计与实施
梅建军， 陈建芳 - 微生物学通报, 2022 - wswxtb.ijournals.cn
… of Medical Immunology with the content in the diagnosis and treatment protocol of COVID-19
and … Cytokine storm by COVID-19 and treatment strategy of traditional Chinese medicine[J]. …
and … Cytokine storm by COVID-19 and treatment strategy of traditional Chinese medicine[J]. …